Point72 Asset Management, L.P.

Position in ALXO — Alx Oncology Holdings Inc

CIK 1603466 STAMFORD, CT

Position in ALXO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$82,395

+$59,550 QoQ

Shares Held

41,095

+103.3% QoQ

Ownership

0.031%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#39

of 68 holders

Holding Since

Sep 2022

7 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Point72 Asset Management, L.P. holds $2,393,298,297 across 187 Biotechnology names. ALXO ranks #171 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APLS	Apellis Pharmaceuticals, Inc.	4,183,918	$168,319,021
2	MDGL	Madrigal Pharmaceuticals, Inc.	225,510	$118,047,719
3	CLDX	Celldex Therapeutics, Inc.	3,229,939	$102,453,665
4	RYTM	Rhythm Pharmaceuticals, Inc.	846,801	$73,646,282
5	AXSM	Axsome Therapeutics, Inc.	424,750	$71,791,245
6	ABVX	Abivax S.A.	637,736	$71,011,903
7	LEGN	Legend Biotech Corp	3,886,017	$70,298,047
8	JAZZ	Jazz Pharmaceuticals plc	358,634	$67,799,757

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$82,395	41,095	+103.3%	Shares	Defined	2026-05-15
2025-12-31	$22,845	20,217	-93.4%	Shares	Defined	2026-02-17
2024-06-30	$1,833,723	304,100	-66.7%	Shares	Defined	2024-09-16
2023-12-31	$13,604,993	913,700	+6640.2%	Shares	Defined	2024-02-14
2023-03-31	$61,273	13,556	-84.1%	Shares	Defined	2023-05-15
2022-12-31	$957,950	85,000	-77.8%	Shares	Defined	2023-05-15
2022-09-30	$3,660,525	382,500	—	Shares	Defined	2022-11-14
No filing history on record for this holder in this stock.